Co-Authors
This is a "connection" page, showing publications co-authored by Katie Kompoliti and Christopher Goetz.
Connection Strength
1.917
-
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22.
Score: 0.219
-
TikTok Tics: A Pandemic Within a Pandemic. Mov Disord Clin Pract. 2021 Nov; 8(8):1200-1205.
Score: 0.208
-
Menstrual-related changes in motoric function in women with Parkinson's disease. Neurology. 2000 Nov 28; 55(10):1572-5.
Score: 0.198
-
Therapeutic approaches. Adv Neurol. 2000; 82:217-21.
Score: 0.186
-
Neuropharmacology in the elderly. Neurol Clin. 1998 Aug; 16(3):599-610.
Score: 0.169
-
Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome. Mov Disord. 1998 May; 13(3):477-80.
Score: 0.166
-
Tourette syndrome. Clinical rating and quantitative assessment of tics. Neurol Clin. 1997 May; 15(2):239-54.
Score: 0.155
-
Association between antipsychotics and body mass index when treating patients with tics. J Child Adolesc Psychopharmacol. 2010 Aug; 20(4):277-81.
Score: 0.097
-
Dysautonomia rating scales in Parkinson's disease: sialorrhea, dysphagia, and constipation--critique and recommendations by movement disorders task force on rating scales for Parkinson's disease. Mov Disord. 2009 Apr 15; 24(5):635-46.
Score: 0.089
-
Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects. Mov Disord. 2006 Feb; 21(2):248-52.
Score: 0.071
-
Estrogen supplementation in the posthypoxic myoclonus rat model. Clin Neuropharmacol. 2001 Jan-Feb; 24(1):58-61.
Score: 0.050
-
Application of the Unified Parkinson's Disease Rating Scale in progressive supranuclear palsy: factor analysis of the motor scale. Mov Disord. 2000 Mar; 15(2):276-9.
Score: 0.047
-
"On" freezing in Parkinson's disease: resistance to visual cue walking devices. Mov Disord. 2000 Mar; 15(2):309-12.
Score: 0.047
-
Effects of central dopaminergic stimulation by apomorphine on speech in Parkinson's disease. Neurology. 2000 Jan 25; 54(2):458-62.
Score: 0.047
-
Movement disorders in Kuru. Mov Disord. 1999 Sep; 14(5):800-4.
Score: 0.045
-
Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102.
Score: 0.042
-
Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 1998 Jul; 55(7):957-61.
Score: 0.042
-
Progressive cognitive decline with truncal/limb ataxia and ballistic movements. Mov Disord. 1997 Nov; 12(6):1075-84.
Score: 0.040